Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)

COVID-IHU #25

Version 1 du 08 Juillet 2020

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)

Didier Raoult1,2, Matthieu Million1,2, Philippe Gautret1,3, Jean-Christophe Lagier1,2, Philippe Colson1,2, Philippe Parola1,3, and Jean-Marc Rolain1,2

Lire l’article

Relais de brève

Lire la suite sur le site relayé...

Author: Redaction